RecruitingNot ApplicableNCT06358664

Caffeine and Cataract After Pars Plana Vitrectomy

The Effect of Caffeine Consumption on Cataract Formation After Pars Plana Vitrectomy: a Comparative Study


Sponsor

Vienna Institute for Research in Ocular Surgery

Enrollment

74 participants

Start Date

Apr 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Assessment of cataract development in patients with regular caffeine consumption and those without caffeine consumption after pars plana vitrectomy.


Eligibility

Min Age: 18 YearsMax Age: 105 Years

Inclusion Criteria5

  • Age 18 or older
  • Written informed consent
  • No previous cataract surgery in the study eye
  • Scheduled small gauge vitrectomy with intraoperative gas tamponade (SF6 or C3F8) due to retinal detachment or macular hole repair
  • No regular caffeine consumption (drinking not more than one cup of a caffeine- containing beverage \[e.g. coffee, energy drinks\] at a maximum of two days per week during the past year)

Exclusion Criteria6

  • Intake of systemic or topical corticosteroids within 3 months before study screening
  • Increased risk for postoperative cataract development, for example due to ocular trauma in the history
  • Severe cataract (LOCS III grading of any cataract form >2) in the study eye at pre- study screening
  • Scheduled phacovitrectomy in the study eye
  • Participation in any clinical trial three month before study screening
  • Ocular surgeries six month before study screening

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREPars plana vitrectomy

Standard pars plana vitrectomy will be performed


Locations(1)

Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital, Vienna

Vienna, Austria

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06358664


Related Trials